BCL2 and Miyoshi myopathy: Using this STA model, we determined NFκB pathway activity in Affymetrix microarray datasets that include purified PC at multiple stages of disease and from diverse MM subsets, and correlated NFκB pathway activity with mRNA expression encoding pro-survival BCL-2 family members.